Home » U.S. FDA Issues Guidances to Spur First-In-Human Studies
U.S. FDA Issues Guidances to Spur First-In-Human Studies
December 8, 2011
The U.S. Food and Drug Administration (FDA) proposes to streamline device clinical trials in a pair of draft guidances outlining requirements for early feasibility studies and explaining when a trial can begin even when there are outstanding issues with an Investigational Device Exemption (IDE) submission.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor